New York, New York, United States Caxton Associates appeared to be the VC, which was created in 1983. The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the New York.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The increased amount of exits for fund were in 2018. The top activity for fund was in 2010. The fund is generally included in less than 2 deals every year.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Health Care, Pharmaceutical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Anthera Pharmaceuticals, Synta Pharmaceuticals.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the Caxton Associates, startups are often financed by VantagePoint Capital Partners, Sofinnova Investments, Pappas Ventures. The meaningful sponsors for the fund in investment in the same round are SunAmerica, OrbiMed, Mountain Trail Investments.
Related Funds
| Fund Name | Location |
| Aramex International | Amman, Amman, Jordan |
| Corisol Holding AG | Switzerland, Zug, Zug |
| New Leaf Ventures | British Columbia, Canada, Vancouver |
| Persei Venture | - |
| Shanghai Gesi Xinxi Jishu Youxian Gongsi | China, Shanghai |
| SL2 Capital | - |
| South Western School District | South Carolina, Spartanburg, United States |
| Women's Growth Capital Fund | District of Columbia, United States, Washington |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Synta Pharmaceuticals | $50M | 14 Jan 2004 | Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Synta Pharmaceuticals | $50M | 14 Jan 2004 | Massachusetts, United States |
